GleamWall
中文EN

CARL CARLSMED, INC.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1794546 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY60.4%
TTM net income YoY-55.6%
TTM EPS YoY65.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin77.0%
Operating margin-59.0%
Net margin-55.8%
FCF margin-48.6%
EBITDA margin-58.4%

Returns

ROE-43.9%
ROA-32.0%
ROIC (approx.)-108.1%
Asset turnover0.57x

Leverage & solvency

Liabilities / assets34.4%
Debt / equity0.20x
Current ratio5.79x
Interest coverage-33.33x

Cash quality & payout

Operating cash flow / net income0.86x
Accruals ratio-4.6%
Payout ratio—
Capex / revenue0.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$21.55M$18.94M$16.12M$15.16M$13.07M$12.08M$10.19M$9.41M
Cost of revenue$4.89M$4.40M$3.69M$3.56M$3.15M$3.21M$2.55M$2.38M
Gross profit$16.66M$14.54M$12.43M$11.61M$9.93M$8.87M$7.64M$7.02M
R&D expense$6.38M$6.04M$5.18M$5.26M$4.45M$4.16M$3.15M$3.02M
SG&A expense$9.98M$7.62M$6.23M$4.85M$4.91M$3.34M$3.47M$2.33M
Operating income-$12.70M-$11.04M-$9.28M-$9.32M-$9.04M-$6.50M-$5.72M-$4.70M
Interest expense$316,000$313,000$311,000$330,000$380,000$363,000$357,000$378,000
Income tax$0$0$0$0$0$0$0$0
Net income-$12.24M-$10.51M-$8.70M-$8.61M-$8.53M-$6.77M-$5.73M-$4.72M
EBITDA-$12.60M-$10.94M-$9.18M-$9.22M-$8.94M-$6.40M-$5.68M-$4.66M
EPS (basic)-0.45-0.39-0.32—-0.40-1.47-1.47—
EPS (diluted)-0.45-0.39-0.32—-0.40-1.47-1.47—
Weighted avg. shares (diluted)27.30M27.19M26.84M—21.08M4.59M4.30M—
Balance sheet
Cash & equivalents$35.95M$46.24M$73.02M$85.79M$115.37M$33.47M$43.43M$40.12M
Short-term investments$24.00M$24.00M$24.00M$24.00M———$0
Receivables$16.88M$13.78M$12.27M$11.36M$11.30M$9.71M—$6.77M
Inventory$2.99M$2.27M$2.06M$1.84M$1.34M$1.07M—$995,000
Current assets$105.56M$109.60M$115.41M$126.67M$131.47M$46.19M—$49.35M
PP&E, net$3.61M$2.40M$1.60M$1.49M$1.19M$972,000—$260,000
Total assets$115.27M$118.20M$118.77M$130.12M$134.86M$53.27M—$51.82M
Current liabilities$18.24M$12.40M$9.71M$14.28M$10.93M$9.48M—$8.82M
Long-term debt$15.40M$15.38M$15.36M$15.35M$15.44M$15.43M—$15.41M
Total debt$15.40M$15.38M$15.36M$15.35M$15.44M$15.43M—$15.41M
Total liabilities$39.60M$33.96M$26.52M$31.25M$28.20M$27.61M—$26.23M
Shareholders' equity$75.67M$84.25M$92.25M$98.87M$106.66M-$83.07M-$76.61M-$70.63M
Net debt-$20.55M-$30.86M-$57.65M-$70.45M-$99.93M-$18.04M—-$24.71M
Shares outstanding27.39M27.23M27.18M26.60M26.58M4.60M—4.14M
Cash flow statement
Operating cash flow-$8.67M-$7.36M-$13.01M-$5.32M-$8.46M-$7.04M-$8.15M-$4.20M
Capital expenditure$283,000$121,000$79,000$73,000$159,000$327,000$83,000$61,000
Free cash flow-$8.96M-$7.48M-$13.09M-$5.39M-$8.62M-$7.37M-$8.24M-$4.26M
Investing cash flow-$1.80M-$19.66M-$206,000-$24.23M-$343,000-$672,000-$238,000-$61,000
Financing cash flow$172,000$243,000$436,000-$29,000$90.70M-$2.25M$11.70M-$51,000
Depreciation & amortization$100,000$100,000$99,000$98,000$100,000$100,000$40,000$37,000
Stock-based compensation$3.28M$2.27M$1.63M$790,000$704,000$258,000$175,000$100,000

Free plan shows the latest 8 periods; Pro shows all 11 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.